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Abstract: Arterial elasticity changes in familial hypercholesterolemia (FH) and diabetes 
mellitus (DM) with different but overlapping mechanisms. We compared aortic elasticity between 
19 FH patients with the same mutation, 18 type 2 DM patients, and 30 controls, all aged 48 
to 64. They underwent aortic magnetic resonance imaging, risk-factor assessment, and carotid 
and femoral ultrasound measurements. All patients were on adequate cardiovascular medication 
including statins and had established coronary heart disease (CHD). FH patients had longer-
duration CHD (13.3 ± 7.7 years) than did DM patients (5.0 ± 3.1). Aortic compliance in the 
descending thoracic (DM 0.38 ± 0.14 vs control 0.53 ± 0.19, P = 0.032) and abdominal aorta 
(DM 0.45 ± 0.20 vs control 0.66 ± 0.25, P = 0.011) was lower in DM patients than in controls, 
whereas no signiﬁ  cant difference existed between FH patients and controls. Carotid and femoral 
intima-media thickness was greater in FH and DM patients than in controls with no difference 
between patient groups. Carotid or femoral plaques appeared in 15 (79%) FH and in 10 (56%) 
DM patients. One control had a femoral plaque. Five FH patients showed stenosis, occlusion 
or both in carotid arteries. In our opinion, DM patients’ lower compliance reﬂ  ect mainly arte-
rial media affecting arteriosclerosis, while FH patients’ plaque status and longer duration of 
CHD suggest more advanced atherosclerosis. The FH patients may therefore be at increased 
risk for atherothrombotic events. However, due to small patient material, larger conﬁ  rmatory 
studies are needed.
Keywords: MRI, ultrasound, familial hypercholesterolemia, diabetes mellitus, elasticity, 
intima-media thickness
Introduction
Diabetes mellitus (DM) is a common cause of excess mortality, approximately half 
of which results from cardiovascular diseases (Morgan et al 2000). The prevalence 
of DM is rising worldwide (Wild et al 2004) and causing growing expenses for the 
health care system in addition to life-years lost.
Another disease causing excess cardiovascular mortality is familial hypercholes-
terolemia (FH) (Anonymous 1999). In FH, a hereditary low-density lipoprotein (LDL) 
receptor defect results, from birth, in impaired hepatic cholesterol uptake, which in 
heterozygotes leads to 2- to 3-fold higher blood cholesterol levels than normal. This 
results in accelerated atherosclerosis. The prevalence of heterozygous FH is 1/500 
worldwide (Goldstein et al 2001).
Both DM and FH are risk factors for atherosclerosis, which is associated with 
decreased arterial elasticity (van Popele et al 2001) in addition to plaque formation. 
Endothelial dysfunction, inﬂ  ammation, ﬁ  brosis, and calciﬁ  cation of the arterial 
intima are the proposed mechanisms. Another mechanism leading to reduction in 
arterial elasticity is arteriosclerosis. This term associated with DM and aging refers Vascular Health and Risk Management 2008:4(5) 1104
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to degradation of elastin, proliferation of collagen, and 
deposition of calcium in the media and adventitia in contrast 
to changes in the intima in atherosclerosis (Safar 2007). 
These two mechanisms for loss of arterial elasticity often 
overlap (Safar 2007), however, and the terms are sometimes 
confusingly interchanged.
Atherosclerosis of different vascular beds show positive 
association (Sternby 1968) and magnetic resonance imaging 
(MRI) is an established method to study vessel wall elastic-
ity (Oliver and Webb 2003). In our previous study on young 
heterozygous FH patients carotid intima-media thickness 
(IMT) correlated with aortic elasticity markers (pulse wave 
velocity and complience) assessed with MRI (Soljanlahti 
et al 2008).
Careful risk factor treatment, statins in particular (Smilde 
et al 2001), may slow down the atherosclerotic process or 
cause even regression of atherosclerotic lesions. The results 
of our earlier MRI studies on young (6 to 48 years of age) 
heterozygous FH patients and healthy controls are in line with 
this showing no difference between groups in aortic morphol-
ogy and function (Soljanlahti et al 2008) or brain lesions of 
vascular origin (Soljanlahti et al 2005). The purpose of the 
present study was to assess the elastic properties of aorta 
with MRI in patients with more advanced FH disease. The 
results were compared with DM, in which aortic compli-
ance is decreased due to arterio- and atherosclerosis (Safar 
2007). We also compared the aortic data to the carotid and 
femoral IMT, a measure of overall atherosclerosis, assessed 
with ultrasound (US).
Material and methods
Patients
The patient register of the North Karelia Central Hospital 
(Joensuu, Finland) contained data on 30 FH patients 48 to 
64 years of age who had the same DNA-veriﬁ  ed (Koivisto 
et al 1993) North Karelia (NK) mutation in year 2003. The 
mutation produces similar phenotype (tendon xanthomas, 
2–3-fold elevation in LDL cholesterol) like other receptor 
defective FH mutations. They also had coronary heart 
disease (CHD) veriﬁ  ed from medical records and by physical 
examination. Eight of them were excluded because 3 also 
had DM, 1 had a body mass index (BMI) of 46, 2 had an 
unreliable diagnosis of CHD, 1 was unable to travel, and 1 
was unreachable. Of the remaining 22 patients, 19 agreed 
to participate.
The same CHD criteria and the same patient register as 
for FH-NK patients was used to ﬁ  nd 22 sex- and age-matched 
type 2 DM patients who had been treated at the department 
of internal medicine of the North Karelia Central hospital. 
Two were excluded because they did not use statin medica-
tion. Of the remaining 20 patients, 18 (aged 51–64) agreed 
to participate.
All FH-NK and DM patients used statin medication. 
See Table 1 for their cardiovascular medication and 
Table 1 Characteristics and cardiovascular medication of controls, DM, and FH-NK patients
DM 
(n = 18)
FH-NK 
(n = 19)
Controls 
(n = 29)
P-value
Males/females, no. 11/7 11/8 13/16
Age, y 57.9 ± 3.7 55.9 ± 4.5 56.0 ± 3.8 0.210
BMI, kg/m2 32.6 ± 4.8 26.7 ± 2.8 25.9 ± 3.5 0.000 (DM   FH; 
DM   CTRL; 
FH = CTRL)
Systolic blood pressure, mmHg 143 ± 21 137 ± 23 130 ± 14 0.081
Diastolic blood pressure, mmHg 83 ± 13 78 ± 10 79 ± 9 0.179
Statin usage, y 5.2 ± 2.9 15.1 ± 1.3 0 0.000a
Duration of CHD, y 5 ± 3.1 13.3 ± 7.6 0 0.000a
Statins, users 18 19 0
Beta blockers, users 18 18 1
Acetylsalicylic acid, users 16 17 0
ARB or ACE inhibitors, users 11 3 0
Smokers 3 3 0
Notes: Values are means ± SD unless otherwise stated. aFH and DM groups compared.
Abbreviations: DM, diabetes mellitus; FH-NK, familial hypercholesterolemia-North Karelia; BMI, body mass index; CHD, coronary heart disease;   ACE, angiotensin-converting 
enzyme; ARB, angiotensin-receptor blockers.Vascular Health and Risk Management 2008:4(5) 1105
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characteristics. All FH-NK patients and 17 of the 18 DM 
patients had had AMI, a coronary bypass operation, or 
balloon angioplasty. Two DM and two FH-NK patients had 
each had transient ischemic attack (TIA), and one FH-NK 
patient had a history of ischemic stroke. No other patients 
had any history of neurological diseases.
The control group comprised 30 controls (aged 49–63) 
recruited among acquaintances of the Helsinki Medical Imag-
ing Center (Helsinki, Finland) staff. None of the controls 
had CHD, DM, or history of any vascular or neurological 
disease. One control was excluded because of Moya-Moya 
disease detected in brain MRI.
A medical ethics committee approved the study with 
informed consent obtained from all subjects.
MRI
MRI was performed with a 1.5T Siemens Sonata imager 
(Erlangen, Germany) with a phased array coil. A breath-hold 
oblique sagittal TSE sequence (TR/ TE/ Flip Angle/ FOV/ 
Matrix/ Slice Thickness = 47/ 1.6/ 65 /298*340/148*256/6) 
of the aorta was taken to assess the imaging planes for 
the cine sequence (TR/ TE/ Flip Angle/ FOV/ Matrix /Slice 
Thickness = 28/3.2/30/223*340/156*256/5) taken at the level 
of the right pulmonary artery and at the level of the renal 
artery. Time resolution was 28 ms.
Electrocardiogram gating was used with all sequences. 
Due to poor image quality, one DM patient and one control 
were excluded from analysis of compliance of the ascending 
aorta and descending thoracic aorta, and one FH patient was 
excluded from descending abdominal aorta measurement.
The images were analyzed with Siemens Leonardo 
workstation’s Argus software (Erlangen, Germany) by 
S.S. who was blinded to the clinical and laboratory data 
and had 5 years of experience with the measurements. 
Compliance (%/mmHg) was calculated from the cine images 
by the equation: ([Amax-Amin]/Amin*100)/(Ps-Pd), where 
Amax = maximum luminal area, Amin = minimal luminal 
area, Ps = systolic blood pressure, and Pd = diastolic blood 
pressure (Mohiaddin et al 1989).
Ultrasound
One experienced radiologist (K.L.) performed all ultrasound 
examinations with an 8–12 Mhz linear transducer. The 
subjects were examined in the supine position. IMT was 
measured with high-resolution B-mode (Pignoli et al 1986) 
for the far wall of each common carotid artery 1 cm below 
the bifurcation, and of the left femoral artery at the level 
of the inguinal ligament, and the mean of 3 consecutive 
measurements was calculated. The carotid bifurcations and 
the left femoral artery were examined for plaques. Doppler 
ﬂ  ow measurements were performed to assess the severity of 
arterial stenoses caused by the plaques. Stenosis of 70% or 
more was considered signiﬁ  cant (Grant et al 2003). Ultra-
sound data for two controls were unavailable.
Laboratory tests
After overnight fasting, each subject provided a venous blood 
sample. Serum total cholesterol, triglycerides, high-density 
lipoprotein (HDL) cholesterol, fasting glucose, glycosylated 
hemoglobin, homocysteine, liproprotein a, insulin, and high-
sensitivity C-reactive protein (hsCRP) were determined by 
standard methods. The LDL cholesterol value was calculated by 
the Friedewald formula. To take into account each participant’s 
lifelong cholesterol burden, we calculated the cholesterol-years 
score, as suggested by Hoeg and colleagues (1994). Blood 
pressure was measured twice with an automatic meter from the 
left arm of the patient lying supine, with the mean of two mea-
surements used in the calculations. One control was excluded 
from laboratory assessments because her anti-inﬂ  ammatory 
therapy was started between the MR examination and labora-
tory tests. Because infections can elevate CRP level beyond 
that associated with inﬂ  ammation in cardiovascular diseases 
(Ridker 2003), 4 DM patients whose hsCRP levels exceeded 
10 mg/L were thus excluded from CRP analysis.
Statistical methods
Variables between the groups (controls, FH, and DM patients) 
were compared with ANOVA or the Kruskal-Wallis test, as 
appropriate. A P-value   0.05 was considered statistically 
signiﬁ  cant.
Results
MRI
DM patients had signiﬁ  cantly less compliant descending 
thoracic and abdominal aorta than did controls, but this 
difference did not reach signiﬁ  cance in ascending aorta. 
No signiﬁ  cant difference existed between FH-NK and DM 
patients (Figure 1).
Ultrasound
In all vessels, IMT appeared signiﬁ  cantly greater in the 
FH-NK and DM patients than in the controls (Figure 2). No 
signiﬁ  cant differences appeared between FH-NK and DM 
patients. Carotid or femoral plaques appeared in 15 (79%) 
FH-NK and in 10 (56%) DM patients. Only one control 
had a plaque, and it was in femoral artery (Figure 3). Five Vascular Health and Risk Management 2008:4(5) 1106
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FH patients showed stenosis, occlusion or both in carotid 
arteries: four showed stenosis, the left internal carotid artery 
was occluded in one, and another had occlusion of the right 
internal carotid artery. None of the DM patients or controls 
showed signiﬁ  cant stenosis or occlusion.
Laboratory tests
Cholesterol-years score and total and LDL cholesterol level 
of the FH-NK patients were greater than those of DM patients 
and controls. DM patients had higher trigycerides, fasting 
glucose, insulin, percentage of glycosylated hemoglobin, 
homocysteine, and hsCRP than did FH-NK patients and 
controls (Table 2).
Discussion
Compliance of the descending aorta was lowest in the DM 
patients and highest in controls, but no signiﬁ  cant difference 
emerged between FH and DM patients. Carotid and femoral 
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Figure 1 Aortic Compliance.
Note: Bars indicate mean, whiskers ± SD.
Abbreviations: DM, diabetes mellitus; FH-NK, familial hypercholesterolemia-North Karelia; SD, standard deviation.
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IMT of DM and FH patients was greater than that of the 
controls, with no difference between IMT of FH and DM 
patients. Only the FH patients had signiﬁ  cant carotid stenoses 
or occlusions; they also had more plaques than either DM 
patients or controls.
Our obese DM patients had compliance of the descend-
ing aorta lower than that of controls. This is in concordance 
with a recent MRI study showing lower aortic elasticity than 
in their 16 controls in 14 type 2 DM patients averaging 55 
years of age and without any complications (van der Meer 
et al 2007). In addition, decreased aortic elasticity appeared 
in the MRI of 21 healthy obese (BMI > 30) men compared 
to 25 lean (BMI 19–25) controls (Danias et al 2003), all 20 
to 40 years old. The aortic compliance of our FH patients 
was lower than in controls, although their difference was 
not signiﬁ  cant. This is in line with an aortic MRI study on 
10 relatively young (34 years old on average) asymptomatic 
heterozygous FH patients with no difference in compliance 
compared to that of controls (Toikka et al 1999) and with 
our earlier study on healthy 6- to 48-year-old FH patients 
with no difference in aortic compliance compared to that 
of controls (Soljanlahti et al 2008). Our FH patients with 
veriﬁ  ed CHD were expected to have decreased aortic com-
pliance, as CHD is associated with lower aortic elasticity 
(Mohiaddin et al 1989; Forbat et al 1998). Their improved 
risk-factor treatment, statin treatment in particular, may 
have had beneﬁ  cial effects on compliance, an effect shown 
in one MRI study of 64 hypercholesterolemic patients 
(Forbat et al 1998).
The carotid and femoral IMT of our DM and FH patients 
was higher than that of the controls as expected. Our FH 
patients had more carotid and femoral plaques than did DM 
patients or controls. Only the FH patients had occlusions and 
signiﬁ  cant stenoses of carotid arteries suggesting the most 
advanced atherosclerosis. In the atherosclerotic process, an 
increase in IMT precedes plaque formation (Zureik et al 
2000). While statins cause regression of atherosclerotic 
lesions (Smilde et al 2001) and calciﬁ  cations (Callister et al 
1998; Williams et al 1998), to our knowledge, information 
is lacking on their effect on severely stenosed arteries. CHD 
duration was longer in our FH than DM patients (Table 1). 
The reason for a higher number of plaques in our FH patients 
may be their long exposure to high cholesterol concentra-
tions, before statin treatment in the late 1980’s became 
available. In addition, the current cholesterol levels of our 
FH patients exceeded those of the DM patients despite statin 
treatment (Table 2). Furthermore, before statin treatment, 
FH patients showed a risk for strokes over 20-fold compared 
to general population (Kaste and Koivisto 1988). Statins 
provide effects beyond cholesterol lowering (Miida et al 
2007), ones which may stabilize atherosclerotic plaques 
and prevent strokes and other atherothrobotic events. Our 
FH patients showed no more brain lesions than did controls 
(Soljanlahti et al 2007).
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The major limitation of our study is the relatively small 
number of patients and controls. This may explain why no 
signiﬁ  cant difference was found in compliance between FH 
patients compared to DM patients and controls.
We conclude that compliance of the descending aorta 
was lowest in DM patients and highest in controls, with no 
signiﬁ  cant difference between FH and DM patients. Carotid 
and femoral IMT was greater in FH and DM patients than in 
controls. FH patients had more plaques and were the only ones 
with stenoses in carotid arteries. We theorize that the differences 
between FH and DM reﬂ  ect the differences between athero- and 
arteriosclerosis. Furthermore, the plaque status of FH patients 
suggests that they are probably more prone to thromboembolic 
complications of atherosclerosis than are DM patients; their 
statin treatment, however, may lower the risk. Due to small 
sample size, larger studies are needed to conﬁ  rm the ﬁ  ndings 
since arterio- and atherosclerosis are overlapping processes.
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